Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


The RND1 Small GTPase: Main Functions and Emerging Role in Oncogenesis.

Mouly L, Gilhodes J, Lemarié A, Cohen-Jonathan Moyal E, Toulas C, Favre G, Sordet O, Monferran S.

Int J Mol Sci. 2019 Jul 24;20(15). pii: E3612. doi: 10.3390/ijms20153612. Review.


RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma.

Boyrie S, Delmas C, Lemarié A, Lubrano V, Dahan P, Malric L, Luis J, Gilhodes J, Tosolini M, Mouly L, Lehmann M, Toulas C, Cohen-Jonathan Moyal E, Monferran S.

Oncotarget. 2018 Sep 18;9(73):33788-33803. doi: 10.18632/oncotarget.26082. eCollection 2018 Sep 18.


Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells.

Malric L, Monferran S, Delmas C, Arnauduc F, Dahan P, Boyrie S, Deshors P, Lubrano V, Da Mota DF, Gilhodes J, Filleron T, Siegfried A, Evrard S, Kowalski-Chauvel A, Moyal EC, Toulas C, Lemarié A.

Mol Cancer Res. 2019 Feb;17(2):384-397. doi: 10.1158/1541-7786.MCR-18-0386. Epub 2018 Sep 28.


PARP-1-dependent RND1 transcription induced by topoisomerase I cleavage complexes confers cellular resistance to camptothecin.

Mouly L, Mamouni K, Gence R, Cristini A, Cherier J, Castinel A, Legrand M, Favre G, Sordet O, Monferran S.

Cell Death Dis. 2018 Sep 12;9(9):931. doi: 10.1038/s41419-018-0981-3.


Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update.

Malric L, Monferran S, Gilhodes J, Boyrie S, Dahan P, Skuli N, Sesen J, Filleron T, Kowalski-Chauvel A, Cohen-Jonathan Moyal E, Toulas C, Lemarié A.

Oncotarget. 2017 Aug 21;8(49):86947-86968. doi: 10.18632/oncotarget.20372. eCollection 2017 Oct 17. Review.


Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance.

Dahan P, Martinez Gala J, Delmas C, Monferran S, Malric L, Zentkowski D, Lubrano V, Toulas C, Cohen-Jonathan Moyal E, Lemarie A.

Cell Death Dis. 2014 Nov 27;5:e1543. doi: 10.1038/cddis.2014.509.


RhoB promotes γH2AX dephosphorylation and DNA double-strand break repair.

Mamouni K, Cristini A, Guirouilh-Barbat J, Monferran S, Lemarié A, Faye JC, Lopez BS, Favre G, Sordet O.

Mol Cell Biol. 2014 Aug;34(16):3144-55. doi: 10.1128/MCB.01525-13. Epub 2014 Jun 9.


RhoB promotes cancer initiation by protecting keratinocytes from UVB-induced apoptosis but limits tumor aggressiveness.

Meyer N, Peyret-Lacombe A, Canguilhem B, Médale-Giamarchi C, Mamouni K, Cristini A, Monferran S, Lamant L, Filleron T, Pradines A, Sordet O, Favre G.

J Invest Dermatol. 2014 Jan;134(1):203-212. doi: 10.1038/jid.2013.278. Epub 2013 Jun 21.


Radiation-induced mitotic cell death and glioblastoma radioresistance: a new regulating pathway controlled by integrin-linked kinase, hypoxia-inducible factor 1 alpha and survivin in U87 cells.

Lanvin O, Monferran S, Delmas C, Couderc B, Toulas C, Cohen-Jonathan-Moyal E.

Eur J Cancer. 2013 Sep;49(13):2884-91. doi: 10.1016/j.ejca.2013.05.003. Epub 2013 Jun 6.


P2Y2 receptor inhibits EGF-induced MAPK pathway to stabilise keratinocyte hemidesmosomes.

Faure E, Garrouste F, Parat F, Monferran S, Leloup L, Pommier G, Kovacic H, Lehmann M.

J Cell Sci. 2012 Sep 15;125(Pt 18):4264-77. doi: 10.1242/jcs.097600. Epub 2012 Jun 20.


Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration.

Taboubi S, Garrouste F, Parat F, Pommier G, Faure E, Monferran S, Kovacic H, Lehmann M.

Mol Biol Cell. 2010 Mar 15;21(6):946-55. doi: 10.1091/mbc.E09-06-0497. Epub 2010 Jan 20.


Alphavbeta3/alphavbeta5 integrins-FAK-RhoB: a novel pathway for hypoxia regulation in glioblastoma.

Skuli N, Monferran S, Delmas C, Favre G, Bonnet J, Toulas C, Cohen-Jonathan Moyal E.

Cancer Res. 2009 Apr 15;69(8):3308-16. doi: 10.1158/0008-5472.CAN-08-2158. Epub 2009 Apr 7.


Alphavbeta3 and alphavbeta5 integrins control glioma cell response to ionising radiation through ILK and RhoB.

Monferran S, Skuli N, Delmas C, Favre G, Bonnet J, Cohen-Jonathan-Moyal E, Toulas C.

Int J Cancer. 2008 Jul 15;123(2):357-364. doi: 10.1002/ijc.23498.


Activation of RhoB by hypoxia controls hypoxia-inducible factor-1alpha stabilization through glycogen synthase kinase-3 in U87 glioblastoma cells.

Skuli N, Monferran S, Delmas C, Lajoie-Mazenc I, Favre G, Toulas C, Cohen-Jonathan-Moyal E.

Cancer Res. 2006 Jan 1;66(1):482-9.


The double life of the Ku protein: facing the DNA breaks and the extracellular environment.

Muller C, Paupert J, Monferran S, Salles B.

Cell Cycle. 2005 Mar;4(3):438-41. Epub 2005 Mar 31. Review.


The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9.

Monferran S, Paupert J, Dauvillier S, Salles B, Muller C.

EMBO J. 2004 Oct 1;23(19):3758-68. Epub 2004 Sep 23.


The Membrane-associated form of the DNA repair protein Ku is involved in cell adhesion to fibronectin.

Monferran S, Muller C, Mourey L, Frit P, Salles B.

J Mol Biol. 2004 Mar 26;337(3):503-11.


Inhibition of Ku heterodimer DNA end binding activity during granulocytic differentiation of human promyelocytic cell lines.

Muller C, Monferran S, Gamp AC, Calsou P, Salles B.

Oncogene. 2001 Jul 19;20(32):4373-82.


Supplemental Content

Loading ...
Support Center